Raymond James Financial Inc. Acquires New Shares in Columbia Research Enhanced Value ETF (NYSEARCA:REVS)

Raymond James Financial Inc. bought a new position in shares of Columbia Research Enhanced Value ETF (NYSEARCA:REVS) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 38,590 shares of the company’s stock, valued at approximately $954,000. Raymond James Financial Inc. owned approximately 2.14% of Columbia Research Enhanced Value ETF at the end of the most recent quarter.

Separately, Pine Valley Investments Ltd Liability Co lifted its position in Columbia Research Enhanced Value ETF by 2.5% in the 3rd quarter. Pine Valley Investments Ltd Liability Co now owns 28,472 shares of the company’s stock valued at $723,000 after acquiring an additional 700 shares in the last quarter.

Columbia Research Enhanced Value ETF Trading Down 5.7 %

REVS stock opened at $22.67 on Friday. The stock has a 50-day moving average price of $25.41 and a two-hundred day moving average price of $25.57. Columbia Research Enhanced Value ETF has a 1 year low of $22.56 and a 1 year high of $27.03. The stock has a market cap of $58.94 million, a PE ratio of 17.30 and a beta of 0.83.

Columbia Research Enhanced Value ETF Company Profile

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.